Furthermore, we identified sub-groups (codon 273 mutant and/or low YAP1 level) of MGMT unmethylated recurrent chemotherapy-treated astrocytoma that responded well to chemotherapy. This evidence concerns the gene YAP1 and astrocytoma (excluding glioblastoma).